Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Approved Rx

1

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

DNA

1

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1978

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Advanced bladder cancer

1

Metastatic ovarian tumors

1

Metastatic testicular tumors

1

Non-small cell lung cancer

1

Unknown

1

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

1

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Non-penetrant

1

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Peyrone, M.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CHEBI

1

DAILYMED

1

DRUG BANK

1

ECHA (EC/EINECS)

1

EU-Orphan Drug

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ANTINEOPLASTIC AGENTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

OTHER ANTINEOPLASTIC AGENTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Platinum compounds

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "VATC|ANTINEOPLASTIC AGENTS|OTHER ANTINEOPLASTIC AGENTS|Platinum compounds|cisplatin" in comments (approximate match)

Showing 1 - 1 of 1 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

CISPLATIN

Q20Q21Q62J

Export Data
Search for Structure

Status:

US Approved Rx (1978)

First approved in 1978

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Conditions:

Advanced bladder cancer

Metastatic ovarian tumors

Metastatic testicular tumors

Non-small cell lung cancer

Platinous chloride is used as a catalyst in organic synthesis. The salt is insoluble in water.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1